BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,006,000 | +3.4% | 19,884 | -0.3% | 0.46% | +7.8% |
| Q2 2022 | $2,907,000 | +16.5% | 19,949 | -5.2% | 0.42% | +52.7% |
| Q1 2022 | $2,495,000 | -45.8% | 21,044 | -37.0% | 0.28% | -28.8% |
| Q4 2021 | $4,602,000 | -2.5% | 33,395 | -1.7% | 0.39% | -6.3% |
| Q3 2021 | $4,718,000 | +38.0% | 33,965 | -3.6% | 0.42% | +38.8% |
| Q2 2021 | $3,420,000 | +32.4% | 35,228 | -6.8% | 0.30% | +24.6% |
| Q1 2021 | $2,583,000 | -21.2% | 37,790 | -1.3% | 0.24% | -17.0% |
| Q4 2020 | $3,280,000 | +7.0% | 38,270 | -18.8% | 0.29% | +20.9% |
| Q3 2020 | $3,065,000 | – | 47,141 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |